A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas

Infantile Hemangioma Tumor Size and C/T Polymorphism Within CTCF Binding Site Six

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00974129

Enrollment

Registered

2009-09-10

Start date

2009-09-30

Completion date

2012-06-30

Last updated

2014-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemangioma

Brief summary

The purpose of this study is to evaluate the genotype of CTCF, a proven transcription factor, in patients with infantile hemangiomas and to monitor tumor growth. The investigators aim to determine whether or not the CTCF genotype might serve as an early and reliable predictor of tumor growth.

Detailed description

This study seeks to examine a potential relationship between CTCF genotype and hemangioma size and growth rate. In addition to the initial visit, patients will return to our clinic for evaluation at two weeks, one month, two months, six months, and one year. At each visit, patients' hemangiomas will be measured and photographed. At one point over the course of evaluation, a blood sample will be taken from each patient for evaluation of C/T polymorphism at CTCF binding site six.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 1 Years

Healthy volunteers

Yes

Inclusion criteria

* Hemangioma must appear within one month prior to enrollment

Exclusion criteria

* Hemangioma appeared before one month prior to enrollment

Countries

United States

Outcome results